Halozyme Appoints Former CFO David Ramsay as Interim Financial Leader Starting March 23
David Ramsay will rejoin Halozyme as interim CFO effective March 23, 2026, overseeing all financial operations while the company searches for a permanent chief financial officer. Ramsay previously served as Halozyme’s CFO from 2003–2009 and 2013–2015, guiding it from a private startup to a billion-dollar public biopharmaceutical company.
1. Interim CFO Appointment
David Ramsay will assume the role of interim CFO on March 23, 2026, overseeing all financial operations while the company seeks a permanent CFO.
2. Extensive Past Leadership
Ramsay previously served as Halozyme’s CFO from 2003 to 2009 and again from 2013 to 2015, steering the company’s evolution from a private startup to a billion-dollar public biopharma firm.
3. Ongoing Executive Search
Halozyme has engaged a leading executive search firm to identify a new permanent CFO with capital markets expertise and strategic management skills.
4. Strategic Continuity Implications
Ramsay’s return is expected to ensure continuity in investor relations and financial strategy, providing stability during the CFO transition and supporting ongoing strategic priorities.